share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit

SEC announcement ·  Jun 8 04:14
Summary by Futu AI
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.